Status:

COMPLETED

Acupuncture for Chemotherapy-Induced Nausea and Vomiting

Lead Sponsor:

Tianjin University of Traditional Chinese Medicine

Conditions:

Chemotherapy-induced Nausea and Vomiting

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of this study is to clarify whether the matching acupoints is more effective than a single point by electroacupuncture in the management of chemotherapy-induced nausea and vomiting .

Detailed Description

Patients were assigned to Four sessions of electroacupuncture(EA) at the CV12, ST36, CV12+ST36 acupoints or antiemetic therapy over 5 days. primary and secondary outcomes and Adverse Eventswill be ass...

Eligibility Criteria

Inclusion

  • Be diagnosed as cancer and need to accept chemotherapy.
  • The score of Karnofsky ≥70
  • Patients of either gender and older than 18 years
  • Patients receiving chemotherapy both outpatients and inpatients
  • Patients receiving chemotherapy either he first or multiple cycle, but the patient will be taken in only one time
  • To receive chemotherapy containing cisplatin(DDP≥75mg/m2) or joint chemotherapy programmes of Anthracyclines(Adriamycin≥40mg/m2 or epirubicin≥60mg/m2)
  • Life expectancy≥ 6 months
  • Willing to participate in the study and be randomized into one of the four study groups.

Exclusion

  • To receive radiotherapy and chemotherapy
  • Gastrointestinal tumors
  • Patients with serious liver disease or abnormal hepatorenal function (AST,ACT, and TBIL are 3 times more than normal, BUN and Cr are 2 times more than normal)
  • Presence of cardiac pacemaker
  • Active skin infection
  • Nausea and/or vomiting resulting from opioids or metabolic imbalance (electrolyte disturbances)
  • Patients unable to provide self-care or communication
  • Nausea and/or vomiting resulting from mechanical risk factors (i.e., intestinal obstruction)
  • Brain metastases
  • Women in pregnant and lactating period

Key Trial Info

Start Date :

April 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2017

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT02195921

Start Date

April 1 2015

End Date

January 1 2017

Last Update

February 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tianjin University of Traditional Chinese Medicine

Tianjin, Tianjin Municipality, China, 301617